Warning labels on Mounjaro, Ozempic, and a whole host of other similar type 2 diabetes drugs list gastrointestinal problems, such as the following, as potential side effects associated with them: Abdominal discomfort or pain Nausea Bloating Vomiting Constipation Discolored stools Indigestion Diarrhea However, in entering Ozempic, Mounjaro, and other similar medications into the FDA Adverse Events Reporting System (FAERS) Public Dashboard, thousands of reports of much more serious adverse side effects, including the following, come up: Pancreatitis Gallbladder issues Kidney failure Thyroid tumors Cancer Gastroparesis Gastroparesis, also known as stomach paralysis, is what has led to many patients filing lawsuits against the drugs manufacturers most recently
Your healthcare provider can then assess the situation, conduct necessary diagnostic tests, and determine the appropriate course of action
Ethics declarations Ethics approval and consent to participate The study was approved by the Ethical Committee of the hospital and informed consent was obtained from the patients or their family who had agreed to participate in the study
This preparation contains a total peptide content exceeding the labelled amount based on independent analytical verification
Regular monitoring ensures safe and effective treatment
Some regain faster if they return to pre-treatment eating habits immediately, while others stabilize at an intermediate weight if they've maintained new behavioral patterns
